Mixed Data for Warfarin Dosing By Genotype

AHA 2013 — DALLAS — For patients requiring anticoagulation for atrial fibrillation, venous thromboembolism, or some other indication, genotype-guided dosing of warfarin and similar drugs might have some benefit, three trials showed.

Keywords: AHA Annual Scientific Sessions


< Back to Listings